TSE:APHA - Aphria Inc. (APHA.TO) Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: C$8.52
  • Forecasted Upside: 42.26 %
  • Number of Analysts: 5
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 4 Buy Ratings
  • 0 Strong Buy Ratings
C$5.99
▲ +0.03 (0.50%)
1 month | 3 months | 12 months
Get New Aphria Inc. (APHA.TO) Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for APHA and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for APHA

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
C$8.52
▲ +42.26% Upside Potential
This price target is based on 5 analysts offering 12 month price targets for Aphria Inc. (APHA.TO) in the last 3 months. The average price target is C$8.52, with a high forecast of C$11.00 and a low forecast of C$6.50. The average price target represents a 42.26% upside from the last price of C$5.99.
Buy
The current consensus among 5 investment analysts is to buy stock in Aphria Inc. (APHA.TO).

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/10/2019
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/8/2019
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/6/2019
  • 0 strong buy ratings
  • 3 buy ratings
  • 1 hold ratings
  • 0 sell ratings
2/4/2020
  • 0 strong buy ratings
  • 5 buy ratings
  • 1 hold ratings
  • 0 sell ratings
5/4/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings
8/2/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings
10/1/2020
  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings
10/31/2020

Latest Recommendations

  • 0 strong buy ratings
  • 4 buy ratings
  • 1 hold ratings
  • 0 sell ratings

DateBrokerageActionRatingPrice TargetDetails
10/22/2020Jefferies Financial GroupLower Price TargetC$10.00 ➝ C$9.42
i
10/16/2020CormarkBoost Price TargetC$6.00 ➝ C$7.00
i
10/16/2020CIBCBoost Price TargetC$7.50 ➝ C$8.00
i
10/16/2020Pi FinancialSet Price TargetBuyC$10.00
i
10/9/2020Stifel NicolausBoost Price TargetC$8.00 ➝ C$8.25
i
8/5/2020Jefferies Financial GroupLower Price TargetC$9.00 ➝ C$7.00
i
7/30/2020Pi FinancialBoost Price TargetBuyC$8.00 ➝ C$10.00
i
7/30/2020CIBCBoost Price TargetC$6.00 ➝ C$7.50
i
4/16/2020CIBCLower Price TargetC$7.00 ➝ C$6.00
i
4/16/2020Eight CapitalUpgradeNeutral ➝ BuyC$9.00 ➝ C$8.00
i
4/16/2020Jefferies Financial GroupLower Price TargetC$10.00 ➝ C$9.00
i
4/16/2020Stifel NicolausBoost Price TargetC$4.50 ➝ C$5.30
i
4/14/2020Pi FinancialSet Price TargetBuyC$8.00
i
3/19/2020Bank of AmericaUpgradeNeutral ➝ Buy
i
2/19/2020Bryan, Garnier & CoLower Price TargetC$12.40 ➝ C$6.50
i
1/21/2020Alliance Global PartnersReiterated RatingBuyC$11.00
i
1/20/2020Jefferies Financial GroupLower Price TargetC$11.00 ➝ C$10.30
i
1/15/2020Pi FinancialLower Price TargetBuyC$9.00 ➝ C$8.00
i
1/15/2020CIBCUpgradeUnderperform ➝ NeutralC$6.50 ➝ C$7.00
i
10/16/2019CormarkLower Price TargetC$14.00 ➝ C$8.00
i
10/16/2019Eight CapitalLower Price TargetC$11.00 ➝ C$9.00
i
10/16/2019CIBCLower Price TargetC$7.00 ➝ C$6.50
i
10/11/2019Jefferies Financial GroupLower Price TargetC$15.00 ➝ C$11.00
i
8/2/2019CIBCBoost Price TargetC$6.50 ➝ C$7.00
i
7/26/2019CIBCLower Price TargetC$12.00 ➝ C$6.50
i
6/19/2019Canaccord GenuityLower Price TargetC$18.00 ➝ C$16.00
i
5/24/2019Jefferies Financial GroupReiterated RatingBuyC$15.00
i
4/17/2019CormarkLower Price TargetC$15.00 ➝ C$14.00
i
4/16/2019CIBCBoost Price TargetC$10.00 ➝ C$12.00
i
10/14/2018Bryan, Garnier & CoSet Price TargetBuyC$31.00
i
7/18/2018Canaccord GenuityLower Price TargetC$11.25C$25.50 ➝ C$24.50
i
1/30/2018Canaccord GenuityBoost Price TargetC$23.50 ➝ C$26.50
i
1/11/2018Canaccord GenuitySet Price TargetSpeculative BuyC$23.00
i
1/11/2018Pi FinancialBoost Price TargetC$14.00 ➝ C$25.00
i
12/5/2017Canaccord GenuityBoost Price TargetC$8.25 ➝ C$14.00
i
(Data available from 10/31/2015 forward)
Aphria Inc. (APHA.TO) logo
Aphria Inc. cultivates, processes, produces, markets, distributes, and sells medical cannabis in Canada and internationally. The company offers pharmaceutical-grade medical cannabis, adult-use cannabis, and cannabis-derived extracts and derivative cannabis products under the Solei, RIFF, Good Supply, Aphria, P'tite Pof, and Broken Coast brands. It serves patients and consumers through distributors and online. The company is headquartered in Leamington, Canada.
Read More

Today's Range

Now: C$5.99
C$5.75
C$5.99

50 Day Range

MA: C$6.24
C$5.62
C$8.00

52 Week Range

Now: C$5.99
C$2.65
C$8.29

Volume

2,110,693 shs

Average Volume

3,220,552 shs

Market Capitalization

C$1.73 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A